Physician profile
Andrew B Ebert
NPI 1841339785
$11,271.41
in general payments reported to CMS, 2019-2025
25 companies · $2,673 in 2025
The $2,673 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $226 · 2021: $1,497 · 2022: $2,886 · 2023: $247 · 2024: $2,087 · 2025: $2,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,684 · Travel and Lodging: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,683.78 |
| Travel and Lodging | $2,323.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,883.97 | 2019-2025 | |
| Miach Orthopaedics, INC. | $1,544.66 | 2023-2025 | |
| Smith+Nephew, INC. | $1,512.28 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Shoulder Innovations, INC. | $1,411.76 | 2024 | Inset System |
| Arthrex, INC. | $337.22 | 2025 | |
| Zimmer Biomet Holdings, INC. | $249.76 | 2021-2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $249.33 | 2019-2021 | |
| Bioventus LLC | $189.72 | 2019-2025 | Xcell |
| Davol INC. | $188.65 | 2024 | Arista Ah Flexitip |
| Linvatec Corporation | $159.81 | 2024 | Biobrace 23mm |
| Stryker Corporation | $77.08 | 2019-2021 | |
| Vericel Corporation | $66.25 | 2022-2025 | Maci |
| Kowa Pharmaceuticals America, INC. | $57.41 | 2023 | Seglentis |
| Next Science LLC | $51.05 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $47.71 | 2024-2025 | Zilretta, Iovera |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $44.37 | 2019-2022 | |
| Ethicon US, LLC | $33.67 | 2022 | |
| Fx Shoulder Solutions, INC | $29.02 | 2019 | |
| Innovation Technologies INC | $26.48 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.09 | 2022 | |
| Avanos Medical | $23.66 | 2019 | |
| Zyla Life Sciences, INC. | $17.49 | 2019 | |
| Arthrosurface Incorporated | $16.79 | 2019 | |
| Abbott Laboratories | $15.66 | 2023 | Prodigy |
| Pfizer INC. | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.